Cellvax moves to new laboratory facility in ENVA

Cellvax is a French service company which provides complete in vitro & in vivo preclinical innovating services allowing to accelerate the drug development process for unmet needs related with severe human diseases, mainly in oncology field.

Cellvax was created in 2001 as a French SME by a motivated and complementary team consisting of scientists and experts in these fields. By offering its know-how and its capacity of innovation, Cellvax has successfully accomplished numerous in vitro and in vivo studies for different companies in Europe, Israel and in the world.

Cellvax's expertise is based on its know-how in in vitro models, especially original in vivo models. These services can be offered to all laboratories involving in anti-cancer drug development process. These proposed services adapt to the validation and development of anti-cancer drug candidates and are fully validated such as sub-cutaneous and orthotopic tumors models in animals; in vitro and in vivo angiogenesis models; an original "Nodule" system, tumor invasion tests, in vivo imaging, bio-distribution, pharmacokinetics, toxicity, histological analysis, biomarker studies, ...

Cellvax is always ready to obey market evolution and to satisfy its customers' specific needs all over the world. In order to enhance its development and continuously satisfy its customers, Cellvax has recently moved to a new laboratory facility, just on the border of Paris, inside "Ecole Nationale Veterinaire Alfort" (ENVA). The ENVA is one of the oldest and largest veterinary universities in Europe, created in 1766, with an easy access by subway. The ENVA is located on a large surface of 110 000 metres squared, with more than one thousand people (Scientists, Professors, technicians, students, ...) working here. In this new facility, Cellvax is able to provide to its customers a number of new services especially with different species of animals (mice, rats, rabbits, dogs, minipigs, etc.), spontaneous naturally-developed tumors, in vivo imaging plat-forms, MRI, Scanner, Scintigraphy, histological analysis, biomarkers.

In summary, Cellvax is able to provide to its customers the services not only in small animals, but also in large animals in a more efficient way.




The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blocking IL-11 protein extends lifespan and health in mice by 25%, study shows